Nurix Therapeutics (NRIX) Cash from Operations Growth (1y) (2020 - 2026)
Nurix Therapeutics (NRIX) Cash from Operations Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 356.73% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Nurix Therapeutics | 2.64 Bn | 2.19 Bn | - | -52.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -52.90% |
| Feb 28, 2026 | -17.72% |
| Nov 30, 2025 | -39.14% |
| Aug 31, 2025 | -36.06% |
| May 31, 2025 | -59.08% |
| Feb 28, 2025 | -45.62% |
| Nov 30, 2024 | -282.66% |
| Aug 31, 2024 | -2.54% |
| May 31, 2024 | -114.98% |
| Feb 29, 2024 | 13.42% |
| Nov 30, 2023 | 170.32% |
| Aug 31, 2023 | 11.18% |
| May 31, 2023 | 43.89% |
| Feb 28, 2023 | -13.66% |
| Nov 30, 2022 | -22.79% |
| Aug 31, 2022 | -54.50% |
| May 31, 2022 | -4.37% |
| Feb 28, 2022 | -629.37% |
| Nov 30, 2021 | -50.92% |
| Aug 31, 2021 | -388.06% |